188 related articles for article (PubMed ID: 6390814)
1. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates.
Menitove JE; Frenzke M; Aster RH
Transfusion; 1984; 24(6):528-31. PubMed ID: 6390814
[TBL] [Abstract][Full Text] [Related]
2. Use of PGE1 for preparation of platelet concentrates.
Menitove JE; Frenzke M; Aster RH
Transfusion; 1986; 26(4):346-50. PubMed ID: 2941906
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.
Elias M; Heethuis A; Weggemans M; Bom V; Blom N; McShine RL; Halie MR; Smit Sibinga CT
Ann Hematol; 1992 Jun; 64(6):292-8. PubMed ID: 1379080
[TBL] [Abstract][Full Text] [Related]
4. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
[TBL] [Abstract][Full Text] [Related]
5. Platelet function in platelet concentrates and in whole blood.
Rodgers SE; Lloyd JV; Russell WJ
Anaesth Intensive Care; 1985 Nov; 13(4):355-61. PubMed ID: 2934002
[TBL] [Abstract][Full Text] [Related]
6. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
7. Preservation of platelet function in cryopreserved platelet concentrates with prostacyclin.
Johnson EJ; Mackie IJ; Machin SJ; Brozović B
Clin Lab Haematol; 1984; 6(2):141-4. PubMed ID: 6207975
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
9. Quality assessment of platelet concentrates supplemented with second-messenger effectors.
Rivera J; Lozano ML; Corral J; Connor J; Gónzález-Conejero R; Ferrer F; Currie L; Vicente V
Transfusion; 1999 Feb; 39(2):135-43. PubMed ID: 10037122
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin prolongs viability of washed human platelets.
Blackwell GJ; Radomski M; Vargas JR; Moncada S
Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of platelets componentized with the Reveos Automated Blood Processing System and stored for 7 days at room temperature in a non-Di(2-ethylhexyl) phthalate (DEHP) platelet pooling set.
Reddoch-Cardenas KM; Perez SL; Ferdin JN; Meledeo MA
Transfusion; 2024 May; 64 Suppl 2():S146-S154. PubMed ID: 38491915
[TBL] [Abstract][Full Text] [Related]
12. Biological actions of prostacyclin and its pharmacological use in platelet studies.
Moncada S; Whittle BJ
Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
[No Abstract] [Full Text] [Related]
13. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
14. ENDOTHELIUM-DERIVED INHIBITORS EFFICIENTLY ATTENUATE THE AGGREGATION AND ADHESION RESPONSES OF REFRIGERATED PLATELETS.
Reddoch KM; Montgomery RK; Rodriguez AC; Meledeo MA; Pidcoke HF; Ramasubramanian AK; Cap AP
Shock; 2016 Feb; 45(2):220-7. PubMed ID: 26555740
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with transfusion of leukocyte-poor platelet concentrates prepared by filtration with prostacyclin.
van Prooijen HC; Riemens TI; Akkerman JW
Blood; 1987 Jul; 70(1):243-6. PubMed ID: 3297202
[TBL] [Abstract][Full Text] [Related]
16. Storage of single-donor platelet concentrates: metabolic and functional changes.
Böck M; Glaser A; Pfosser A; Schleuning M; Heim MU; Mempel W
Transfusion; 1993 Apr; 33(4):311-5. PubMed ID: 8480351
[TBL] [Abstract][Full Text] [Related]
17. Myocardial ischemia: platelet and thromboxane concentrations in cardiac lymph and the effects of ibuprofen and prostacyclin.
Michael LH; Hunt JR; Lewis RM; Entman ML
Circ Res; 1986 Jul; 59(1):49-55. PubMed ID: 3524894
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
19. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
20. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
Manrique RV; Manrique V
Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
